Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;34(9):947-53.
doi: 10.1086/671725. Epub 2013 Jul 17.

Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern community

Ritu Banerjee  1 , Jacob Strahilevitz, James R Johnson, Payal P Nagwekar, Donna M Schora, Ilene Shevrin, Hongyan Du, Lance R Peterson, Ari Robicsek
Affiliations

Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern community

Ritu Banerjee et al. Infect Control Hosp Epidemiol. 2013 Sep.

Abstract

Objective: To identify predictors of community-onset extended-spectrum β-lactamase (ESBL)-producing Escherichia coli infection.

Design: Prospective case-control study.

Setting: Acute care hospitals and ambulatory clinics in the Chicago, Illinois, region.

Patients: Adults with E. coli clinical isolates cultured in ambulatory settings or within 48 hours of hospital admission.

Methods: Cases were patients with ESBL-producing E. coli clinical isolates cultured in ambulatory settings or within 48 hours of admission, and controls were patients with non-ESBL-producing E. coli isolates, matched to cases by specimen, location, and date. Clinical variables were ascertained through interviews and medical record review. Molecular methods were used to identify ESBL types, sequence type ST131, and aac(6')-Ib-cr.

Results: We enrolled 94 cases and 158 controls. Multivariate risk factors for ESBL-producing E. coli infection included travel to India in the past year (odds ratio [OR], 14.40 [95% confidence interval (CI), 2.92-70.95]), ciprofloxacin use (OR, 3.92 [95% CI, 1.90-8.1]), and age (OR, 1.04 [95% CI, 1.02-1.06]). Case isolates exhibited high prevalence of CTX-M-15 (78%), ST131 (50%), and aac(6')-Ib-cr (66% of isolates with CTX-M-15).

Conclusions: Providers should be aware of the increased risk of ESBL-producing E. coli infection among returned travelers, especially those from India.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. All authors report no conflicts of interest relevant to this article. All authors submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest, and the conflicts that the editors consider relevant to this article are disclosed here.

References

    1. Marchaim D, Gottesman T, Schwartz O, et al. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 2010;54:5099–5104. - PMC - PubMed
    1. DeKraker M, Davey P, Grundmann H. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011;8:e1001104. - PMC - PubMed
    1. Tumbarello M, Spanu T, DiBidino R, et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum beta-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother. 2010;54:4085–4091. - PMC - PubMed
    1. Hawkey P, Jones A. The changing epidemiology of resistance. J Antimicrob Chemother. 2009;64:i3–i10. - PubMed
    1. Peirano G, Pitout J. Molecular epidemiology of Escherichia coli producing CTX-M-beta lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents. 2009;35:316–321. - PubMed

Publication types

MeSH terms

LinkOut - more resources